*
*
Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable
54321NA
The skills learned in this CME course enhanced my professional competence.
The skills learned in this CME course will be applied in the treatment of my patients.
*
5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence NA|Not applicable to my practice
54321
Implement targeted therapies for acute myeloid leukemia.
Implement targeted therapies for diffuse large B-cell lymphoma?
Assess next steps in CAR-T cell therapies?
*
Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied NA=Not Applicable
54321NA
From Doublets to Quadruple Combination Therapies for Newly Diagnosed Multiple Myeloma and Beyond: The Transformative Effect of Induction/Remission Therapy Followed by Maintenance in the Era of Novel Therapies - Paul Richardson, M.D.
Update on T-cell Redirecting Therapies for Relapsed/Refractory Multiple Myeloma - Adam Cohen, M.D.
Landscape of Multiple Myeloma Therapies in LATAM: Current Status and Unmet Needs - Patricio Duarte, M.D.
Updates on Treatment Approaches in Diffuse Large B-Cell Lymphoma (DLBCL): Where Are We and Where Are We Heading? - Matthew Matasar, M.D.
Positioning Transplantation and Cellular Therapies in the ‘Other’ B-NHLs (FL, MCL, CLL/SLL) - Craig Sauter, M.D.
Update on Treatment Approaches for T-cell Lymphoma - Steven M. Horwitz, M.D.
Donor-derived Anti-viral Specific T Cells for Treatment of EBV PTLD and Refractory CMV Reactivation - Guenther Koehne, M.D.
Strategies to Enhance Enrollment of Under-served Patients Onto Bone Marrow Transplant and Cellular Therapy Clinical Trials - Juliet Barker, MBBS (Hons), FRACP
AML 2025: Therapeutic Integration of New Agents - Richard Stone, M.D.
Updates on Targeted Therapies in Acure Myeloid Leukemia - Eytan Stein, M.D.
Novel Therapeutic Strategies in Myelofibrosis - Raajit Rampal, M.D.
*
*
*
*
*
*
*
*